Free Trial

Ascentage Pharma Group International (AAPG) Earnings Date, Estimates & Call Transcripts

Ascentage Pharma Group International logo
$21.57 -0.33 (-1.51%)
Closing price 03:59 PM Eastern
Extended Trading
$21.79 +0.22 (+1.02%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ascentage Pharma Group International Earnings Summary

Ascentage Pharma Group International announced Q4 2025 earnings on March 25, 2026, reporting an EPS of -$0.52. Quarterly revenue was reported to be $24.72 million. With a trailing EPS of $0.00, Ascentage Pharma Group International's earnings are expected to grow next year, from ($1.09) to ($0.39) per share.

Q4 2025 Earnings Resources

Actual Revenue
(Mar. 25)
$24.72M
Get Ascentage Pharma Group International Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ascentage Pharma Group International and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Ascentage Pharma Group International Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.09) EPS
Next Year EPS Consensus Estimate
($0.39) EPS

Ascentage Pharma Group International Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/25/2026Q4 2025--$0.5150--$0.5150-$24.72M

Data powered by Fiscal.ai.

Ascentage Pharma Group International Earnings - Frequently Asked Questions

Ascentage Pharma Group International (NASDAQ:AAPG) last announced its quarterly earning data on Wednesday, March 25, 2026. Learn more on AAPG's earnings history.

Ascentage Pharma Group International (NASDAQ:AAPG) has a recorded annual revenue of $82.10 million.

Ascentage Pharma Group International (NASDAQ:AAPG) has a recorded net income of -$177.71 million. AAPG has generated $0.00 earnings per share over the last four quarters.

Ascentage Pharma Group International's earnings are expected to grow from ($1.09) per share to ($0.39) per share in the next year.


This page (NASDAQ:AAPG) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners